reading your article $TSLA re; Tesla gives China victory in the fight in the car market The car markets in Europe and China are currently collapsing in terms of electric vehicles. But now Tesla is helping the Chinese win. Two car markets are crucial for the implementation of electromobility: Europe and China. Because there, CO2 neutral units are especially encouraged. In comparison, the US still relies heavily on combustion engines - although market leader Tesla is coming there.
Europe and China are currently at the forefront of the electric car market. In the first half of 2020, almost 400,000 pure electronic and hybrid cars were sold in Europe. In China, only 7,000 fewer, as mentioned in a message from the Center for Automotive Research (CAR). China gains a lead thanks to Tesla
CAR Director Ferdinand Dudenhöffer is convinced, however, that China will take the lead in the electric car market until the end of the year and will keep it for 50 years. The reason is Tesla: CEO Elon Musk's brand is the leader in China's 16% all-electric vehicle market.
As 80 percent of China's electronic cars are fully electric, the manufacturer's growing production will rapidly increase China's market share. Because the American car manufacturer produces cars directly in China - in a factory in Shanghai.
The economic recovery from the coronavirus pandemic also benefits the Chinese market. There are already signs of increased sales for the second half of the year. Nearly 100,000 electric cars were sold in China in July. This already corresponds to a quarter of the entire first half of the year. Specific approvals for electronic machines
What is also special about China is that registration payments are allocated under a quota system. They are usually auctioned - and cost up to CHF 10,000. But the government has announced additional license plates for free, especially for electronic cars in different cities. In this way, the purchase of electronic cars is highly encouraged.
Chinese Vice Minister of Industry and Information Technology Xin Guobin recently announced that electric cars should account for 25% of the total market by 2025. That would be a good six million electronic cars to be launched in China in 2025. Europe has not been able to keep up with this, the statement said.
$COCP dis is good for shareholders/ $COCP PART TWO, The Rosen Law Firm, P.A. Announces Proposed Class Action Settlement on Behalf of Purchasers of Securities of Cocrystal Pharma, Inc. and/or BioZone Pharmaceuticals, Inc. – COCP GlobeNewswire The Rosen Law Firm PA ,GlobeNewswire•September 7, 2020 NEWARK, N.J., Sept. 07, 2020 (GLOBE NEWSWIRE) -- The Rosen Law Firm, P.A. announces that the United States District Court for the District of New Jersey has approved the following announcement of a proposed class action settlement that would benefit purchasers of securities of Cocrystal Pharma, Inc. and/or BioZone Pharmaceuticals, Inc. (NASDAQ: COCP):
SUMMARY NOTICE OF PENDENCY AND PROPOSED SECURITIES CLASS ACTION SETTLEMENT
TO: ALL PERSONS WHO PURCHASED OR ACQUIRED THE PUBLICLY TRADED SECURITIES OF COCRYSTAL PHARMA, INC. AND/OR BIOZONE PHARMACEUTICALS, INC. BETWEEN SEPTEMBER 23, 2013 AND SEPTEMBER 7, 2018, BOTH DATES INCLUSIVE.
YOU ARE HEREBY NOTIFIED, pursuant to an Order of the United States District Court for the District of New Jersey, that a hearing will be held on December 16, 2020, at 2:00 p.m. before the Honorable Kevin McNulty, United States District Judge of the District of New Jersey, 50 Walnut Street, Courtroom PO 04, Newark, New Jersey 07102 for the purpose of determining:
(1) whether the proposed Settlement of the claims in the above-captioned Action for consideration including the sum of $1,265,000 should be approved by the Court as fair, reasonable, and adequate;
(2) whether the proposed plan to distribute the Settlement proceeds is fair, reasonable, and adequate;
(3) whether the application of Lead Counsel for attorneys’ fees of up to one-third of the Settlement Amount ($421,666.66) plus a proportionate share of interest accrued on the Settlement Amount, Lead Counsel’s reimbursement of litigation expenses incurred of not more than $65,000, and Awards to Plaintiffs of not more than $15,000 in total, should be approved; and
(4) whether the Action should be dismissed with prejudice as set forth in the Stipulation and Agreement of Settlement, fully executed on August 17, 2020 (the “Settlement Stipulation”). The Court reserves the right to hold the Settlement Hearing telephonically or by other virtual means.
The proposed Settlement would resolve the Action alleging that, in violation of the federal securities laws, Defendants
(1) allegedly made misrepresentations and/or omissions of material fact in various public statements concerning an alleged scheme to inflate the price of securities of Cocrystal Pharma, Inc.’s (“Cocrystal” or the “Company”) predecessor, BioZone Pharmaceuticals, Inc. (“BioZone”) and an alleged undisclosed related party transaction, and
(2) allegedly manipulated the market for BioZone securities. Defendants deny the allegations.
If you purchased or acquired the publicly traded securities of Cocrystal and/or BioZone between September 23, 2013 and September 7, 2018, both dates inclusive (“Settlement Class Period”), your rights may be affected by this Settlement, including the release and extinguishment of claims you may possess relating to your ownership interest in Cocrystal securities.
You may obtain copies of the detailed Notice of Pendency and Proposed Settlement of Securities Class Action (“Notice”) and the Proof of Claim and Release Form by writing to or calling the Claims Administrator:
Cocrystal Pharma, Inc. Securities Litigation, c/o Strategic Claims Services, 600 N. Jackson St., Ste. 205, P.O. Box 230, Media, PA 19063; (Tel) (866) 274-4004; (Fax) (610) 565-7985; info@strategicclaims.net. You can also download copies of the Notice and submit your Proof of Claim and Release Form online at http://www.strategicclaims.net.
If you are a member of the Settlement Class, in order to share in the distribution of the Net Settlement Fund,
you must submit a Proof of Claim and Release Form electronically or postmarked
no later than November 16, 2020 to the Claims Administrator,
establishing that you are entitled to recovery.
Unless you submit a written exclusion request, you will be bound by any judgment rendered in the Action whether or not you make a claim.
If you are a Settlement Class Member and desire to be excluded from the Settlement Class, you must submit to the Claims Administrator a request for exclusion so that it is received no later than November 25, 2020, in the manner and form explained in the detailed Notice.
All members of the Settlement Class who have not requested exclusion from the Settlement Class will be bound by any judgment entered in the Action pursuant to the Settlement Stipulation.
Continue reading
Any objection by a Settlement Class Member to the Settlement, Plan of Allocation,
Lead Counsel’s requests for an award to Lead Counsel of attorneys’ fees and reimbursement of expenses and Awards to Plaintiffs must be in the manner and form explained in the detailed Notice and received no later than November 25, 2020, by each of the following:
Clerk of the Court United States District Court District of New Jersey Martin Luther King Building & U.S. Courthouse 50 Walnut Street Newark, NJ 07102 LEAD COUNSEL:
THE ROSEN LAW FIRM, P.A. Phillip Kim 275 Madison Avenue, 40th Floor New York, NY 10016 COUNSEL FOR DEFENDANTS COCRYSTAL PHARMA, INC., GARY WILCOX, JEFFREY MECKLER, GERALD MCGUIRE, JAMES MARTIN, AND CURTIS DALE:
PERKINS COIE LLP Ronald L. Berenstain 1201 Third Avenue, Suite 4900 Seattle, WA 98101 COUNSEL FOR DEFENDANT PHILLIP FROST
MORVILLO ABRAMOWITZ GRAND IASON & ANELLO P.C. Robert J. Anello 565 Fifth Avenue New York, NY 10017 COUNSEL FOR DEFENDANT BARRY HONIG:
WILSON SONSINI GOODRICH & ROSATI Michael Sommer 1301 Avenue of the Americas, 40th Floor New York, NY 10019 COUNSEL FOR DEFENDANTS JOHN STETSON AND STETSON CAPITAL INVESTMENTS, INC.:
MILBANK, LLP Adam Fee 55 Hudson Yards New York, NY 10001 COUNSEL FOR DEFENDANTS MARK GROUSSMAN AND MELECHDAVID, INC.:
BAKER MCKENZIE LLP Perrie Weiner 1901 Avenue of the Stars, Suite 950 Los Angeles, CA 90067 COUNSEL FOR DEFENDANTS JOHN O’ROURKE III AND ATG CAPITAL LLC
ORRICK, HERRINGTON & SUTCLIFFE LLP Randy Luskey 405 Howard Street San Francisco, CA 94105 COUNSEL FOR DEFENDANT JOHN FORD:
CHIESA SHAHINIAN & GIANTOMASI P.C. A. Ross Pearlson One Boland Drive West Orange, NJ 07052 COUNSEL FOR DEFENDANTS MICHAEL BRAUSER AND GRANDER HOLDINGS, INC.
RICHARD AND RICHARD, P.A. Dennis Richard Melissa L. Mackiewicz 825 Brickell Bay Drive Tower III, Suite 1748 Miami, FL 33131 Elliot Maza 550 Sylvan Avenue, Suite 102 Englewood Cliffs, NJ 07632 Brian Keller 5058 Nortonville Way Antioch CA 94531 If you have any questions about the Settlement, you may call or write to Lead Counsel:
THE ROSEN LAW FIRM, P.A. Phillip Kim 275 Madison Avenue, 40th Floor New York, NY 10016 Tel: (212) 686-1060 pkim@rosenlegal.com
PLEASE DO NOT CONTACT THE COURT OR THE CLERK’S OFFICE REGARDING THIS NOTICE.
Dated: August 18, 2020 BY ORDER OF THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF NEW JERSEY
Market Data 
Markets 
AI
